Synthesis and anticancer activity of 1,3,5-triaryl-1H-pyrazole

Letters in Drug Design and Discovery

Volumn 12, Issue 9, 2015, Pages 754-759

  Ghadbeigi, Sajad ^a   Ostad, Seyed Nasser ^a   Shafiee, Abbas ^a   Amini, Mohsen ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AGS; Cytotoxicity; HT 29; MCF 7; Synthesis; Tri arylpyrazole

Indexed keywords

1,3 DIPHENYL 5 PARA TOLYL 1H PYRAZOLE; 1,3,5 TRIARYL 1H PYRAZOLE; 3 (4 FLUOROPHENYL) 1 PHENYL 5 PARA TOLYL 1H PYRAZOLE; 3 (4 FLUOROPHENYL) 1,5 DIPHENYL 1H PYRAZOLE; 3 (4 FLUOROPHENYL) 5 (4 METHOXYPHENYL) 1 PHENYL 1H PYRAZOLE; 3,5 BIS(4 FLUOROPHENYL) 1 PHENYL 1H PYRAZOLE; 5 (2,6 DICHLOROPHENYL) 1,3 DIPHENYL 1H PYRAZOLE; 5 (2,6 DICHLOROPHENYL) 3 (4 FLUOROPHENYL) 1 PHENYL 1H PYRAZOLE; 5 (4 CHLOROPHENYL) 1,3 DIPHENYL 1H PYRAZOLE; 5 (4 CHLOROPHENYL) 3 (4 FLUROPHENYL) 1 PHENYL 1H PYRAZOLE; 5 (4 FLUOROPHENYL) 1,3 DIPHENYL 1H PYRAZOLE; 5 (4 METHOXYPHENYL) 1,3 DIPHENYL 1H PYRAZOLE; ANTINEOPLASTIC AGENT; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

3T3 CELL LINE; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HT 29 CELL LINE; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MOUSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL;

EID: 84942085479     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/1570180812666150326004723     Document Type: Article

References (20)

1. Miralinaghi, P.; Salimi, M.; Amirhamzeh, A.; Nourouzi, M.; Kandelousi, H. M.; Shafiee, A.; Amini, M. Synthesis, molecular docking study, and anticancer activity of triaryl-1, 2, 4-oxadiazole, Med. Chem. Res., 2013, 22, 4253-4262.
2. Assadieskandar, A.; Amini, M.; Ostad, S. N.; Riazi, G. H.; Cheraghi-Shavi, T.; Shafiei, B.; Shafiee A. Design, synthesis, cytotoxic evaluation and tubulin inhibitory activity of 4-aryl-5-(3, 4, 5-trimethoxyphenyl)-2-alkylthio-1H-imidazole derivatives, Bioorg. Med. Chem., 2013, 21, 2703-2709.
3. Elahian, F.; Akbari, M.; Ghasemi, M.; Behtooee, N.; Taheri, M.; Amini, M. Synthesis and anticancer activity of 2, 4, 5-triarly imidazole derivatives, Lett. Drug Des. Discov., 2014, 11, 840-843.
4. Salehi, M.; Amini, M.; Ostad, S. N.; Riazi, G. H.; Assadieskandar, A.; Shafiei, B.; Shafiee, A. Synthesis, cytotoxic evaluation and molecular docking study of 2-alkylthio-4-(2, 3, 4-trimethoxyphenyl)-5-aryl-thiazoles as tubulin polymerization inhibitors, Bioorg. Med. Chem., 2013, 21, 7648-7654.
5. Yadav, M. R..; Chauhan, B. S.; Naik, P.; Gandhi, H.; Giridhar, R. 6, 7-Dimethoxyquinazolines as potential cytotoxic agents: synthesis and in vitro activity, Lett. Drug Des. Discov., 2015, 12, 190-205.
6. Zhang, L.; Wang, J.; Li, W. Y.; Xia, J.; Gao, J.; Yao, Q. Synthesis, in vitro and in vivo anticancer activity of hybrids of 3-hydroxyindolin-2-one and 2, 3-dihydroquinolin-4 (1H)-one, Lett. Drug Des. Discov., 2015, 12, 117-123.
7. Lauria, A.; Terenzi, A.; Gentile, C.; Martorana, A.; Gennaro, G.; Barone, G.; Almerico A. In Silico, Spectroscopic, and biological insights on annelated pyrrolo[3, 2-e]pyrimidines with antiproliferative activity, Lett. Drug Des. Discov., 2014, 11, 15-26.
8. Kurt, Z. K.; Aydin, D.; Isgor, Y. G.; Isgor, B. S.; Olgen S. Synthesis and biological study of novel indole-3-imine-2-one derivatives as src kinase and glutathione S-transferase inhibitors, Lett. Drug Des. Discov., 2013, 10, 19-26.
9. Park, H. J.; Lee, K.; Park, S. I.; Ahn, B.; Lee, J. C.; CHO, H. Y.; Lee K. I. Identification of antitumor activity of pyrazole oxime ethers. Bioorg. Med. Chem. Lett., 2005, 15, 3307-3312.
10. Abadi, A. H.; Eissa, A. A.; Hassan, G. S. Synthesis of novel 1, 3, 4-trisubstituted pyrazole derivatives and their evaluation as antitumor and antiangiogenic agents. Chem. Pharm. Bull., 2003, 51(7), 838-844.
11. Ahsan, M. J.; Khalilullah, H.; Yasmain, S.; Jaday, S. S.; Govindasamy, G. Synthesis, characterisation, and in vitro anticancer activity of curcumin analogues bearing pyrazole/pyrimidine ring targeting EGFR tyrosine kinase, Biomed. Res. Int. 2013, 2013, 1-14.
12. Vossooghi, M.; Amini, M. The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies, Expert Opin. Drug Discov., 2014, 9(3), 255-267.
13. Ibrahim, M. M.; Al-Refai, M.; Abu-El-Halawa, R.; Tashtoush, H.; Alsohaili, S.; Masad, M. Syntheis of some new chalcone and 4, 5-dihydro-1H-pyrazole derivatives as potential antimicrobial agents, Jourdan J. Chem., 7, 115, (2012)
14. Desai, V. G.; Satardekar, P. C.; Polo, S.; Dhumaskar, K. Regioselective synthesis of 1, 3, 5-trisubstitited pyrazoles, Synth. Commun., 2012, 42, 836-842.
15. +• mediated aromatization of 1, 3, 5-trisubstituted pyrazolines, Chin. Chem. Lett., 2008, 19, 1013.1016.
16. 5 in water, Tetrahedron Lett. 2006, 47, 9283-9285.
17. Yu, J.; Kim, K. H.; Moon, H. R; Kim J. N. Facile One-Pot Synthesis of 1, 3, 5-Trisubstituted Pyrazoles from α, β-Enones, Bull. Korean Chem. Soc. 2014, 35, 1692-1696.
18. A. Zarghi, S. Arfaei. Selective COX-2 inhibitors: a review of their structure activity relationships, Iran J. Pharm. Res., 2011, 10(4), 655-831.
19. Tuynman, J. B.; Peppelenbasch, M. P.; Richel, D. J. COX-2 inhibition as a toll to treat and prevent colorectal cancer, Crit. Rev. Oncol. Hematol., 2004, 52, 81-101.
20. Tsujii, M.; Kawano, S.; Du Bois, R. N. Cyclooxygenase-2 expression in human colon cancer cell increases metastatic potential. Proc. Natl. Acad. Sci., USA, 1997, 94, 3336-3340.